Table 2.
The inhibitory effect of MSCs in cancers.
| Cells | Tumors | Mode of action | Results | Ref |
|---|---|---|---|---|
|
BMSCs |
Intracranial aneurysm | EVs | Inhibition | (27) |
| Cervical cancer | EVs | Inhibition | (28) | |
| Colorectal cancer | EVs | Inhibition | (29) | |
| Ovarian cancer | Paracrine | Inhibition | (9) | |
| hMBSCs | Cervical cancer | Paracrine | Inhibition | (16) |
| Hu-ADSCs | Neuroblastoma | Paracrine | Inhibition | (30) |
|
MSCs |
Colorectal cancer | EVs | Inhibition | (22) |
| Glioma | EVs | Inhibition | (31) | |
| hUCESCs | Breast cancer (Rb+) | Cell to cell | Inhibition | (32) |
| hAMSCs | Hepatocellular carcinoma | Paracrine | Inhibition | (17) |
hUCESCs, human uterine cervix-derived MSCs; hAMSCs, human amniotic mesenchymal stem cells; hMBSCs, human menstrual blood-derived stem cells; Hu-ADSCs, human adipose-derived stem cells.